Françoise Heibel

1.6k total citations
14 papers, 452 citations indexed

About

Françoise Heibel is a scholar working on Nephrology, Infectious Diseases and Transplantation. According to data from OpenAlex, Françoise Heibel has authored 14 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Infectious Diseases and 4 papers in Transplantation. Recurrent topics in Françoise Heibel's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Françoise Heibel is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Françoise Heibel collaborates with scholars based in France. Françoise Heibel's co-authors include Bruno Moulin, Peggy Perrin, Sophie Caillard, Jérôme Olagne, Claire Borni-Duval, Laura Braun, Laura Braun-Parvez, C. Müller, Rose‐Marie Javier and Laurence Kessler and has published in prestigious journals such as SHILAP Revista de lepidopterología, Transplantation and American Journal of Transplantation.

In The Last Decade

Françoise Heibel

13 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Françoise Heibel France	8	171	150	121	94	87	14	452
Evaldo Favi Italy	13	100 0.6×	93 0.6×	242 2.0×	123 1.3×	181 2.1×	72	571
H. Hedri Tunisia	11	78 0.5×	48 0.3×	79 0.7×	55 0.6×	108 1.2×	60	345
Annick Massart Belgium	14	147 0.9×	27 0.2×	177 1.5×	30 0.3×	158 1.8×	34	490
Stephen D. Migdal United States	12	127 0.7×	36 0.2×	93 0.8×	74 0.8×	98 1.1×	17	422
P. Pereira Spain	12	78 0.5×	54 0.4×	219 1.8×	31 0.3×	95 1.1×	23	392
Luiz E. Ianhez Brazil	13	74 0.4×	58 0.4×	190 1.6×	94 1.0×	119 1.4×	18	422
D. Burgos Spain	13	101 0.6×	113 0.8×	276 2.3×	74 0.8×	108 1.2×	43	533
B. Erbay Türkiye	11	124 0.7×	22 0.1×	69 0.6×	50 0.5×	80 0.9×	20	401
M.R. Laftavi United States	14	97 0.6×	54 0.4×	370 3.1×	79 0.8×	268 3.1×	48	530
E. Solà Spain	13	84 0.5×	118 0.8×	277 2.3×	76 0.8×	151 1.7×	50	477

Countries citing papers authored by Françoise Heibel

Since Specialization

Citations

This map shows the geographic impact of Françoise Heibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Heibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Heibel more than expected).

Fields of papers citing papers by Françoise Heibel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Heibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Heibel. The network helps show where Françoise Heibel may publish in the future.

Co-authorship network of co-authors of Françoise Heibel

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Heibel. A scholar is included among the top collaborators of Françoise Heibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Heibel. Françoise Heibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dimitrov, Yves, et al.. (2024). Determinants of protective humoral response to mRNA-1273 and BNT162b2 vaccines in peritoneal dialysis patients: a prospective cohort study. BMC Nephrology. 25(1). 391–391. 1 indexed citations

Benotmane, Iliès, Jérôme Olagne, Gabriela Gautier-Vargas, et al.. (2023). Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients. Transplantation. 107(8). e215–e218. 2 indexed citations

Benotmane, Iliès, Aurélie Velay, Gabriela Gautier-Vargas, et al.. (2022). Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients. American Journal of Transplantation. 22(11). 2675–2681. 35 indexed citations

Benotmane, Iliès, Gabriela Gautier-Vargas, Noëlle Cognard, et al.. (2022). Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study. Journal of Personalized Medicine. 12(7). 1107–1107. 4 indexed citations

Grillon, Antoine, et al.. (2018). Bacteriological sampling of peritoneal dialysis fluids. How to limit negative-culture peritonitis rate?. SHILAP Revista de lepidopterología. 1(1). 15–19. 1 indexed citations

Perrin, Peggy, Rose‐Marie Javier, Laura Braun, et al.. (2016). Recent Changes in Chronic Kidney Disease–Mineral and Bone Disorders and Associated Fractures After Kidney Transplantation. Transplantation. 101(8). 1897–1905. 25 indexed citations

Caillard, Sophie, Gabriela Gautier-Vargas, Jérôme Olagne, et al.. (2016). Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation. Transplant International. 30(1). 29–40. 24 indexed citations

Caillard, Sophie, A. Parissiadis, Jérôme Olagne, et al.. (2014). Identification and Long-Term Consequences of Antibodies Which Bound C1q in 118 Kidney Transplant Recipients With Donor Specific Antibodies.. Transplantation. 98. 437–437. 1 indexed citations

Perrin, Peggy, Sophie Caillard, Rose‐Marie Javier, et al.. (2013). Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney Transplantation. American Journal of Transplantation. 13(10). 2653–2663. 119 indexed citations

10.

Borni-Duval, Claire, Sophie Caillard, Jérôme Olagne, et al.. (2013). Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring. Transplantation. 95(12). 1498–1505. 109 indexed citations

11.

Caillard, Sophie, Peggy Perrin, Laura Braun, et al.. (2011). Incidence and Risk Factors of Glucose Metabolism Disorders in Kidney Transplant Recipients: Role of Systematic Screening by Oral Glucose Tolerance Test. Transplantation. 91(7). 757–764. 67 indexed citations

12.

Caillard, Sophie, et al.. (1998). [Post-transplantation lymphomas and Epstein-Barr virus].. PubMed. 19(8). 481–8. 1 indexed citations

13.

Dimitrov, Yves, Françoise Heibel, Louis Marcellin, et al.. (1997). Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrology Dialysis Transplantation. 12(1). 200–203. 22 indexed citations

14.

Mutter, Didier, et al.. (1994). Laparoscopy: An Alternative to Surgery in Patients Treated with Continuous Ambulatory Peritoneal Dialysis. The Nephron journals/Nephron journals. 68(3). 334–337. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact